CYCLO THERAPEUTICS INC (CYTH)
US23254X2018 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 9.25M | 1.54M | 16.61M | 12.85M | 2.78M | |||
| Receivables | 122.38K | 50.00K | 540.00K | 110.00K | 180.00K | |||
| Inventories | 254.35K | 250.00K | 230.00K | 240.00K | 240.00K | |||
| Other Current Assets | 2.69M | 2.31M | 2.06M | 850.00K | 750.00K | |||
| Total Current Assets | 12.32M | 4.16M | 19.44M | 14.05M | 3.96M | |||
| Non-Current Assets | ||||||||
| PPE Net | 929.28K | 60.00K | 80.00K | 90.00K | 60.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 929.28K | 60.00K | 80.00K | 140.00K | 150.00K | |||
| TOTAL ASSETS | 13.25M | 4.22M | 19.52M | 14.19M | 4.11M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 130.00K | 110.00K | N/A | |||
| Accrued Expenses | 2.69M | 0.00 | 20.00K | 20.00K | 20.00K | |||
| Accounts Payable | 5.77M | 3.48M | 3.68M | 3.54M | 3.12M | |||
| Total Current Liabilities | 8.47M | 3.48M | 3.83M | 3.67M | 3.14M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 20.00K | 40.00K | 0.00 | |||
| Other Non-Current Liabilities | 22.48K | N/A | 0.00 | 20.00K | 40.00K | |||
| Total Non-Current Liabilities | 22.48K | 0.00 | 20.00K | 70.00K | 40.00K | |||
| TOTAL LIABILITIES | 8.49M | 3.48M | 3.85M | 3.74M | 3.18M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -83.86M | -63.80M | -48.35M | -34.06M | -25.12M | |||
| Additional Paid In Capital | 88.61M | 64.53M | 64.02M | 44.51M | 26.04M | |||
| Common Shares | 2.86K | 0.00 | 0.00 | 0.00 | 10.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 28.56M | 8.48M | 8.40M | 4.77M | 1.22M | |||
| Tangible Book Value per Share | 0.17 | 0.09 | 1.87 | 2.19 | 0.77 | |||
| Total Shareholders' Equity | 4.76M | 730.00K | 15.67M | 10.45M | 940.00K | |||
| TOTAL LIABILITIES AND EQUITY | 13.25M | 4.22M | 19.52M | 14.19M | 4.11M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.00 | 0.00 | N/A | |||
| Current Ratio | 1.45 | 1.20 | 5.08 | 3.83 | 1.26 | |||
| Return On Assets (ROA) | -151.40% | -366.11% | -73.21% | -63.00% | -183.21% | |||
| Return On Equity (ROE) | -421.64% | -2116.44% | -91.19% | -85.55% | -801.06% | |||
All data in USD